Drugs News and Research

RSS

Insero Health announces top-line Phase Ib trial results of INS001 in patients with drug-resistant epilepsy

Insero Health, Inc., a company developing natural compounds to address unmet medical needs in epilepsy and related neurological disorders, is today reporting top-line results from a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy.

17 May 2013

First Edition: May 17, 2013

Today's headlines include reports about the GOP vote to repeal the health law -- for the 37th time -- as well as how the current IRS scandal is being connected to the health law's implementation.

17 May 2013

Roundup: N.D. abortion clinic sues to stop new law; Health care savings close budget hole in Conn.; Calif. counties struggle to expand mental health care

The running battle over the regulation of abortions entered a North Dakota courtroom on Wednesday, as the state's sole abortion clinic sued to block a new law that it says could force it to shut down. The law, requiring doctors performing abortions to have admitting privileges at a nearby hospital, was promoted by anti-abortion legislators, who argued that it would mean better care for women who suffer medical emergencies (Eckholm, 5/15).

17 May 2013

Simvastatin hinders positive effects of exercise for obese adults, say researchers

Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders including excess body fat and/or high levels of blood pressure, blood sugar and/or cholesterol.

17 May 2013

Scientists identify 4 genes in baboons that influence levels of bad cholesterol

Scientists at the Texas Biomedical Research Institute in San Antonio have identified four genes in baboons that influence levels of "bad" cholesterol. This discovery could lead to the development of new drugs to reduce the risk of heart disease.

17 May 2013

Study reveals that prolonged Dkk1 signaling can lead to fibrosis, stiffening of artery walls

The hardening of arteries is a hallmark of atherosclerosis, an often deadly disease in which plaques, excessive connective tissue, and other changes build up inside vessel walls and squeeze off the flow of oxygen-rich blood throughout the body.

17 May 2013

PCF funds two new Young Investigators in China to lead research projects on prostate cancer

The Prostate Cancer Foundation today announced that it is funding two more Young Investigators in China to lead innovative research projects within the country and expand PCF's global knowledge exchange on game-changing research in prostate cancer.

17 May 2013

NW Bio starts Phase III clinical trial with DCVax-L for brain cancer at King's College Hospital in UK

Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.

17 May 2013

Novel cell sorting enhancement to MoFlo Astrios platform to be introduced by Beckman Coulter Life Sciences at CYTO 2013

Two seminars and seven poster sessions, Beckman Coulter will have a prominent role when CYTO 2013 convenes at the San Diego Convention Center May 18-22, 2013.

From Beckman Coulter Life Sciences - Flow Cytometry 16 May 2013

Study suggests need for better anti-rejection therapies

Transplant researchers at the University of Pittsburgh School of Medicine challenge a long-held assumption about how biologic pathways trigger immune system rejection of donor organs in a report published online today in the Journal of Clinical Investigation.

16 May 2013

Vermont lawmakers OK doc-assisted suicide

The state will become the first to use a legislative vote to legalize physician-assisted suicide after the governor, who has expressed his support for the measure, signs the bill.

16 May 2013

Study finds broader set of concerns for improving quality of life

The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).

16 May 2013

Roundup: Democratic opponents arise over Calif. governor's health care budget cuts; Veto of medical charity tax break scrutinized in Ga.

But Brown vowed to continue to resist pressure from fellow Democrats and interest groups to restore some money to adult dental care and to doctors who treat the poor. … Sacramento will oversee the expansion this year of Medi-Cal, California's health care program for the poor, to more than 1 million Californians who do not have health insurance now.

16 May 2013

Viewpoints: Controversy taints IRS efforts on health law; Another chance to 'gut' the overhaul in the courts; Salt wrongly accused

Even as the politicized tax enforcement scandal expands, the Internal Revenue Service continues to expand its political powers thanks to the Affordable Care Act. A larger government always creates more openings for abuse, as Americans will learn when the IRS starts auditing their health care in addition to their 1040 next year (5/14).

16 May 2013

Mayo Clinic researchers complete world's first whole exome sequence of small intestine carcinoids

Researchers at Mayo Clinic have completed the world's first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy.

16 May 2013

Idelalisib phase 1 clinical trial shows positive results in patients with CLL

A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia, according to a study led in part by Dana-Farber Cancer Institute investigators.

16 May 2013

Drugs News and Research

Insero Health announces top-line Phase Ib trial results of INS001 in patients with drug-resistant epilepsy

First Edition: May 17, 2013

Roundup: N.D. abortion clinic sues to stop new law; Health care savings close budget hole in Conn.; Calif. counties struggle to expand mental health care

Simvastatin hinders positive effects of exercise for obese adults, say researchers

Scientists identify 4 genes in baboons that influence levels of bad cholesterol

Study reveals that prolonged Dkk1 signaling can lead to fibrosis, stiffening of artery walls

PCF funds two new Young Investigators in China to lead research projects on prostate cancer

NW Bio starts Phase III clinical trial with DCVax-L for brain cancer at King's College Hospital in UK

Novel cell sorting enhancement to MoFlo Astrios platform to be introduced by Beckman Coulter Life Sciences at CYTO 2013

Study suggests need for better anti-rejection therapies

Vermont lawmakers OK doc-assisted suicide

Study finds broader set of concerns for improving quality of life

Roundup: Democratic opponents arise over Calif. governor's health care budget cuts; Veto of medical charity tax break scrutinized in Ga.

Viewpoints: Controversy taints IRS efforts on health law; Another chance to 'gut' the overhaul in the courts; Salt wrongly accused

Mayo Clinic researchers complete world's first whole exome sequence of small intestine carcinoids

Idelalisib phase 1 clinical trial shows positive results in patients with CLL

Study finds novel delivery method that helps dissolve stroke-causing clots

Women in 40s continue to undergo routine breast cancer screenings despite new recommendations

Melbourne scientists' discovery may pave way for developing antimalarial drugs

Prostate cancer drug Xofigo gets FDA approval

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News